103 related articles for article (PubMed ID: 1630165)
1. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Di Lorenzo G
Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
[TBL] [Abstract][Full Text] [Related]
4. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
López-Dupla M; Mora Sanz P; Pintado García V; Valencia Ortega E; Uriol PL; Khamashta MA; Aguado AG
Am J Gastroenterol; 1992 Dec; 87(12):1771-6. PubMed ID: 1449139
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
6. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Stevens DA; Greene SI; Lang OS
Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
[TBL] [Abstract][Full Text] [Related]
7. [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome].
Lavilla Uriol P; Gil A; Valencia E; Pintado V; López Dupla M; Khamashta M; García Puig J; Ortiz Vázquez J
Rev Clin Esp; 1992 Feb; 190(3):115-9. PubMed ID: 1561451
[TBL] [Abstract][Full Text] [Related]
8. [The therapy of Candida esophagitis in AIDS patients with fluconazole].
Heise W; Arasteh K; L'age M
Mycoses; 1990; 33 Suppl 1():32-6. PubMed ID: 2101862
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
[TBL] [Abstract][Full Text] [Related]
11. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
[TBL] [Abstract][Full Text] [Related]
14. Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
Péter Z; Horváth Z; Makara M; Telegdy L; Zala J; Zágoni T
Z Gastroenterol; 1996 Jun; 34(6):361-4. PubMed ID: 8767824
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with fluconazole of severe fungal infections in immunocompromised patients].
Boulos M
Rev Inst Med Trop Sao Paulo; 1993; 35(1):81-7. PubMed ID: 8278747
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Gil A; Lavilla P; Valencia E; Pintado V; Dupla ML; Khamashta MA; García-Puig J; Ortiz-Vázquez J
Postgrad Med J; 1991 Jun; 67(788):548-52. PubMed ID: 1924024
[TBL] [Abstract][Full Text] [Related]
17. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
19. Treatment of candida esophagitis in AIDS patients.
Deschamps MM; Pape JW; Verdier RI; DeHovitz J; Thomas F; Johnson WD
Am J Gastroenterol; 1988 Jan; 83(1):20-1. PubMed ID: 3276150
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
